Report of the Inter-Regional Workshop on Intellectual Property Rights in the Context of Traditional Medicine (Bangkok, Thailand, 6-8 December 2000)
(2001; 52 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. The role of intellectual property rights in the context of traditional medicine
Ver el documento3. Globalization, the TRIPS Agreement and access to essential drugs
Ver el documento4. Intellectual property rights
Ver el documento5. Systems and national experience for protecting traditional knowledge, innovations and practices
Abrir esta carpeta y ver su contenido6. Problems and gaps in traditional medicine in relation to modern patent laws
Ver el documento7. Group discussion on existing problems and gaps for the protection of traditional medicine knowledge
Cerrar esta carpeta8. Presentations on national patent law: means, experiences and proposals
Ver el documento8.1. China
Ver el documento8.2. Colombia
Ver el documento8.3. India
Ver el documento8.4. Indonesia
Ver el documento8.5. Kenya
Ver el documento8.6. Pakistan
Ver el documento8.7. Republic of Korea
Ver el documento8.8. WHO Collaborating Centre (Chicago)
Ver el documento9. Recommendations
Ver el documentoAnnex I. Message to the Workshop from Dr Uton Muchtar Rafei, Regional Director WHO South-East Asia Region
Ver el documentoAnnex II. Welcome address from Dr Mongkol Na Songkhla, Permanent Secretary, Ministry of Public Health, Thailand
Ver el documentoAnnex III. Workshop Agenda
Ver el documentoAnnex IV. List of Participants
 

8. Presentations on national patent law: means, experiences and proposals

Seven countries, China, Colombia, India, Indonesia, Kenya, Pakistan and the Republic of Korea, presented papers on their national patent laws, the existing national situation concerning problems, needs, gaps and means in relation to the protection of intellectual property rights in the context of traditional medicine and traditional knowledge. One WHO Collaborating Centre presented a paper on its policy of benefits sharing in research on drugs derived from natural products.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013